Cargando…
Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells
Recent research has shown that chronic lymphocytic leukemia (CLL) B-cells display a strong tendency to differentiate into antibody-secreting cells (ASCs) and thus may be amenable to differentiation therapy. However, the effect of this differentiation on factors associated with CLL pathogenesis has n...
Autores principales: | Ghamlouch, Hussein, Darwiche, Walaa, Hodroge, Ahmed, Ouled-Haddou, Hakim, Dupont, Sébastien, Singh, Amrathlal Rabbind, Guignant, Caroline, Trudel, Stéphanie, Royer, Bruno, Gubler, Brigitte, Marolleau, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621905/ https://www.ncbi.nlm.nih.gov/pubmed/26050196 |
Ejemplares similares
-
A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro
por: Ghamlouch, Hussein, et al.
Publicado: (2013) -
Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells
por: Ghamlouch, Hussein, et al.
Publicado: (2014) -
TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells
por: Ghamlouch, Hussein, et al.
Publicado: (2014) -
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective
por: Darwiche, Walaa, et al.
Publicado: (2018) -
Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia
por: Darwiche, Walaa, et al.
Publicado: (2020)